1. Stoney R, O’dea K, Herbert K, Dragicevic G, Giles G, Cumpston G, et al. Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus. Diabet Med 2001; 18: 476-482.
2. León LE, Rani S, Fernandez M, Larico M, Calligaris SD. Subclinical detection of diabetic cardiomyopathy with microRNAs: challenges and perspectives. J Diabetes Res 2016; 2016: 1-12.
3. Chae CU, Derby CA. The menopausal transition and cardiovascular risk. Obstet Gynecol Clin North Am 2011; 38: 477-488.
4. Sanches IC, Buzin M, Conti FF, da Silva Dias D, dos Santos CP, Sirvente R, et al. Combined aerobic and resistance exercise training attenuates cardiac dysfunctions in a model of diabetes and menopause. PloS One J 2018; 13: 1-15.
5. Saengsirisuwan V, Pongseeda S, Prasannarong M, Vichaiwong K, Toskulkao C. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism 2009; 58: 38-47.
6. Lew JKS, Pearson JT, Schwenke DO, Katare R. Exercise mediated protection of diabetic heart through modulation of microRNA mediated molecular pathways. Cardiovasc diabetol 2017; 16: 1-20.
7. Masi LN, Serdan TDA, Levada-Pires AC, Hatanaka E, dos Reis Silveira L, Cury-Boaventura MF, et al. Regulation of gene expression by exercise-related micrornas. Cell Physiol Biochem 2016; 39: 2381-2397.
8. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996; 335: 453-461.
9. Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 100: 1134-1146.
10. Habibi P, Alihemmati A, Nasirzadeh M, Yousefi H, Habibi M, Ahmadiasl N. Involvement of microRNA-133 and-29 in cardiac disturbances in diabetic ovariectomized rats. Iran J Basic Med Sci 2016; 19:1177-1185.
11. He Y, Ding Y, Liang B, Lin J, Kim T-K, Yu H, et al. A systematic study of dysregulated microRNA in type 2 diabetes mellitus. Int J Mol Sci 2017; 18: 1-23.
12. Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res 2012; 93: 583-593.
13. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation 2010; 121: 1022-1032.
14. Han Y, Chen Y-S, Liu Z, Bodyak N, Rigor D, Bisping E, et al. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ Res 2006; 99: 415-423.
15. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007; 120: 3045-3052.
16. Habibi P, Alihemmati A, NourAzar A, Yousefi H, Mortazavi S, Ahmadiasl N. Expression of the Mir-133 and Bcl-2 could be affected by swimming training in the heart of ovariectomized rats. Iran J Basic Med Sci 2016; 19: 381-387.
17. Ed G. Guide for the care and use of laboratory animals. National Research Council. 8th ed. Washington, DC, USA 2011.
18. Karimi A, Joukar S, Najafipour H, Masoumi-Ardakani Y, Shahouzehi B. Low-intensity endurance exercise plus nandrolone decanoate modulates cardiac adiponectin and its receptors. Auton Autacoid Pharmacol 2017; 37: 29-33.
19. Joukar S, Najafipour H, Dabiri S, Sheibani M, Sharokhi N. Cardioprotective effect of mumie (shilajit) on experimentally induced myocardial injury. Cardiovasc Toxicol 2014; 14: 214-221.
20. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009; 104: 170–178.
21. Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW, Chakrabarti S. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 2014; 18: 415–421.
22. Rawal S, Manning P, Katare R. Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease. Cardiovasc Diabetol 2014; 13: 1-24.
23. Yildirim SS, Akman D, Catalucci D, Turan B. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys 2013; 67: 1397–1408.
24. Anbinder AL, Prado MdA, Spalding M, Balducci I, Carvalho YR, Rocha RFd. Estrogen deficiency and periodontal condition in rats: a radiographic and macroscopic study. Braz Dent J 2006; 17: 201-207.
25. Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int 2014; 2014: 1-11.